62,339 Rxo Inc $RXO Shares Bought by Penn Capital Management Company LLC

Key Points

• Penn Capital increased its RXO stake by 6.4%, buying 62,339 shares in the third quarter to reach 1,037,302 shares, valued at about $21.3 million.
• Analyst sentiment is mostly neutral: RXO has a consensus Hold rating and an average price target of $27.32.
• RXO reported quarterly EPS of $0.09, topping estimates of $0.08, while revenue of $1.87 billion exceeded forecasts and rose 31.7% year over year.

Penn Capital Management Company LLC lifted its position in shares of Rxo Inc (NYSE:RXO - Free Report) by 6.4% during the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 1,037,302 shares of the company's stock after purchasing an additional 62,339 shares during the period. RXO accounts for approximately 1.5% of Penn Capital Management Company LLC's investment portfolio, making the stock its 10th biggest holding. Penn Capital Management Company LLC owned approximately 0.63% of RXO worth $21,266,000 at the end of the most recent reporting period.

Other large investors also recently made changes to their positions in the company. City Holding Co. lifted its holdings in RXO by 227.6% during the 2nd quarter. City Holding Co. now owns 1,245 shares of the company's stock worth $34,000 after purchasing an additional 865 shares during the last quarter. Cassaday & Co Wealth Management LLC acquired a new position in RXO in the 1st quarter valued at $29,000. Nykredit A S bought a new position in RXO during the 2nd quarter worth $67,000. Public Employees Retirement System of Ohio increased its position in RXO by 18.3% during the 1st quarter. Public Employees Retirement System of Ohio now owns 4,196 shares of the company's stock worth $61,000 after buying an additional 649 shares during the period. Finally, Integrated Wealth Concepts LLC bought a new position in RXO during the 2nd quarter worth $133,000. Institutional investors own 92.73% of the company's stock.

Wall Street Analyst Weigh In

A number of equities research analysts have recently issued reports on RXO shares. Stifel Nicolaus set a $31.00 target price on shares of RXO in a research report on Friday, August 7th. BMO Capital Markets downgraded shares of RXO from an "outperform" rating to a "hold" rating and set a $30.25 price target on the stock. in a research note on Tuesday, October 6th. UBS Group raised their price target on shares of RXO from $23.00 to $30.25 and gave the stock a "neutral" rating in a research report on Wednesday, November 4th. Weiss Ratings reiterated a "sell (d-)" rating on shares of RXO in a research note on Tuesday, September 1st. Finally, Benchmark reiterated a "hold" rating on shares of RXO in a research note on Tuesday, July 28th. One research analyst has rated the stock with a Strong Buy rating, three have assigned a Buy rating, fifteen have issued a Hold rating and one has given a Sell rating to the company's stock. According to MarketBeat.com, the stock has a consensus rating of "Hold" and an average target price of $27.32.

RXO Trading Up 1.1%

Shares of NYSE:RXO opened at $27.91 on Tuesday. The company has a market capitalization of $4.60 billion, a P/E ratio of -54.73 and a beta of 1.96. Rxo Inc has a 1 year low of $10.43 and a 1 year high of $29.90. The company has a debt-to-equity ratio of 0.30, a current ratio of 1.28 and a quick ratio of 1.28. The business's 50 day simple moving average is $24.47 and its 200 day simple moving average is $21.40.

RXO (NYSE:RXO - Get Free Report) last posted its quarterly earnings data on Thursday, October 29th. The company reported $0.09 EPS for the quarter, topping analysts' consensus estimates of $0.08 by $0.01. The firm had revenue of $1.87 billion for the quarter, compared to analyst estimates of $1.82 billion. RXO had a negative return on equity of 0.07% and a negative net margin of 1.35%. The company's revenue was up 31.7% on a year-over-year basis. During the same quarter last year, the company earned $0.01 EPS. On average, research analysts anticipate that Rxo Inc will post 0.16 EPS for the current fiscal year.

About RXO

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.